Clinuvel Pharmaceuticals Ltd logo

Clinuvel Pharmaceuticals Ltd (CLVLF)

Market Closed
14 Oct, 08:00 PM
OTC PINK OTC PINK
$
5. 38
0
0%
$
343.8M Market Cap
- P/E Ratio
- Div Yield
300 Volume
- Eps
$ 5.38
Previous Close
Add Transaction
Day Range
5.38 5.38
Year Range
5.38 8.6
Want to track CLVLF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Clinuvel Pharmaceuticals Ltd (CLVLF) Statistics

Valuation metrics

Market Cap 343.8M
Enterprise value 381.77M
Trailing P/E (ttm) 11.68
Forward P/E -
PEG ratio -2.1
Price/Sales (ttm) 4.26
Price/Book (mrq) 1.45
Enterprise Value/Revenue 4.06
Enterprise Value/EBITDA 9.2

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 375
Average volume (90 days) 711

Price summary

52-Week low 5.38
52-Week high 8.6
Beta -
50-Day moving average 6.1
200-Day moving average 6.52

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.05
Trailing annual dividend yield 0.0063%
5-Year annual dividend yield -
Payout ratio 0.07
Dividend Date 18 Sep 2026
Ex-Dividend Date 3 Sep 2026
Last split factor 1:10
Last split Date 18 Nov 2010

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.36%
Operating margin 0.43%

Operational effectiveness

Return on assets 0.11%
Return on equity 0.13%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.89
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.68
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 5.07
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 14.81%
Book value per share (mrq) 5.48

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -